Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic–Induced Weight Gain
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic–Induced Weight Gain
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume 44, Issue 4, Pages 668-679
Publisher
SAGE Publications
Online
2010-03-17
DOI
10.1345/aph.1m550
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin-associated lactic acidosis: A prognostic and therapeutic study*
- (2009) Alexandre Seidowsky et al. CRITICAL CARE MEDICINE
- Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies
- (2009) C. J. Bushe et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metformin for Weight Control in Pediatric Patients on Atypical Antipsychotic Medication
- (2009) Lauren Shin et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2009) Grigori Joffe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial
- (2009) T. Baptista et al. PHARMACOPSYCHIATRY
- Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
- (2009) Edgardo Carrizo et al. SCHIZOPHRENIA RESEARCH
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
- (2008) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Role of Metformin for Weight Management in Patients Without Type 2 Diabetes
- (2008) Alicia R Desilets et al. ANNALS OF PHARMACOTHERAPY
- Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents
- (2008) Roger S. McIntyre et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- An Exploration of the Effect of Modafinil on Olanzapine Associated Weight Gain in Normal Human Subjects
- (2008) James L. Roerig et al. BIOLOGICAL PSYCHIATRY
- Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain
- (2008) Ren-Rong Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
- (2008) H Afshar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study
- (2008) Trino Baptista et al. PSYCHIATRY RESEARCH
- An Overview of Obesity in Children with Psychiatric Disorders Taking Atypical Antipsychotics
- (2008) Lauren Shin et al. HARVARD REVIEW OF PSYCHIATRY
- Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine
- (2007) Chun-Hsin Chen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More